Nature Reviews Drug Discovery published an article "
Gene-editing pipeline takes off"
on May 15, 2020, summarized the clinical trials of genome-editing agents, including CRISPR-Cas9 editors, zinc finger nucleases and TALENs, for ex vivo, immuno-oncology and in vivo treatment. It's really a great resource for learning the advances in gene-editing advances. Below is a screenshot from the article, you can find more information in the original
article.
interesting information!